US Stock MarketDetailed Quotes

Editas Medicine (EDIT)

Watchlist
  • 2.910
  • -0.300-9.35%
Close Apr 24 15:59 ET
  • 2.919
  • +0.009+0.31%
Post 19:42 ET
284.81MMarket Cap-1.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Editas Medicine (EDIT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
25.39%40.52M
-19.16%24.74M
12,265.57%7.54M
597.47%3.58M
310.40%4.66M
-58.64%32.31M
-49.03%30.6M
-98.86%61K
-82.23%513K
-88.48%1.14M
Operating revenue
25.39%40.52M
-19.16%24.74M
12,265.57%7.54M
597.47%3.58M
310.40%4.66M
-58.64%32.31M
-49.03%30.6M
-98.86%61K
-82.23%513K
-88.48%1.14M
Cost of revenue
Gross profit
Operating expense
-48.44%139.86M
-40.34%38.76M
-51.18%32.09M
-59.90%29.04M
-41.33%39.97M
9.68%271.23M
-22.67%64.97M
18.43%65.73M
54.14%72.42M
12.03%68.13M
Selling and administrative expenses
-30.68%49.9M
-30.58%11.35M
-31.91%12.32M
-29.37%12.86M
-30.84%13.38M
3.35%71.99M
13.14%16.35M
20.69%18.09M
5.84%18.21M
-15.95%19.34M
-General and administrative expense
-30.68%49.9M
-30.58%11.35M
-31.91%12.32M
-29.37%12.86M
-30.84%13.38M
3.35%71.99M
13.14%16.35M
20.69%18.09M
5.84%18.21M
-15.95%19.34M
Research and development costs
-54.85%89.95M
-43.63%27.4M
-58.49%19.78M
-70.15%16.18M
-45.49%26.59M
12.16%199.25M
-30.11%48.61M
17.59%47.64M
82.04%54.21M
29.05%48.79M
Operating profit
58.42%-99.34M
59.21%-14.02M
62.62%-24.55M
64.59%-25.46M
47.29%-35.31M
-41.22%-238.92M
-43.40%-34.36M
-30.91%-65.67M
-63.07%-71.9M
-31.46%-66.99M
Net non-operating interest income expense
-84.79%2.14M
78.18%2.14M
-116.09%-568K
-98.44%67K
-90.07%500K
-19.95%14.06M
-76.46%1.2M
-31.38%3.53M
12.75%4.3M
43.49%5.04M
Non-operating interest income
-48.87%8.31M
-50.58%1.68M
-48.13%1.83M
-51.43%2.09M
-46.06%2.72M
-7.48%16.25M
-33.54%3.39M
-31.38%3.53M
12.75%4.3M
43.49%5.04M
Non-operating interest expense
181.78%6.17M
-121.19%-464K
--2.4M
--2.02M
--2.22M
--2.19M
--2.19M
--0
--0
--0
Other net income (expense)
-413.80%-62.86M
6.26M
80.00%-1K
-2,783,900.00%-27.84M
-688,066.67%-41.28M
-662.78%-12.24M
-5K
85.71%-1K
100.38%6K
Special income (charges)
-396.03%-60.67M
151.19%6.26M
--0
---26.08M
---40.85M
---12.23M
---12.23M
--0
--0
--0
-Less：Restructuring and merger&acquisition
396.03%60.67M
-67.21%4.01M
--0
--24.28M
--32.38M
--12.23M
--12.23M
--0
--0
--0
-Less:Other special charges
----
----
----
--1.8M
--4.75M
----
----
----
----
----
-Write off
----
----
--0
--0
--3.72M
----
----
----
----
--0
Other non- operating income (expenses)
-72,866.67%-2.19M
---5K
80.00%-1K
-175,700.00%-1.76M
-7,183.33%-425K
99.81%-3K
----
---5K
85.71%-1K
100.38%6K
Income before tax
32.49%-160.06M
87.62%-5.62M
59.58%-25.12M
21.26%-53.24M
-22.82%-76.09M
-54.74%-237.09M
-140.52%-45.4M
-38.03%-62.14M
-67.80%-67.61M
-26.34%-61.95M
Income tax
Net income
32.49%-160.06M
87.62%-5.62M
59.58%-25.12M
21.26%-53.24M
-22.82%-76.09M
-54.74%-237.09M
-140.52%-45.4M
-38.03%-62.14M
-67.80%-67.61M
-26.34%-61.95M
Net income continuous Operations
32.49%-160.06M
87.62%-5.62M
59.58%-25.12M
21.26%-53.24M
-22.82%-76.09M
-54.74%-237.09M
-140.52%-45.4M
-38.03%-62.14M
-67.80%-67.61M
-26.34%-61.95M
Minority interest income
Net income attributable to the parent company
32.49%-160.06M
87.62%-5.62M
59.58%-25.12M
21.26%-53.24M
-22.82%-76.09M
-54.74%-237.09M
-140.52%-45.4M
-38.03%-62.14M
-67.80%-67.61M
-26.34%-61.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.49%-160.06M
87.62%-5.62M
59.58%-25.12M
21.26%-53.24M
-22.82%-76.09M
-54.74%-237.09M
-140.52%-45.4M
-38.03%-62.14M
-67.80%-67.61M
-26.34%-61.95M
Basic earnings per share
37.50%-1.8
89.09%-0.06
62.67%-0.28
23.17%-0.63
-21.05%-0.92
-42.57%-2.88
-139.13%-0.55
-36.36%-0.75
-46.43%-0.82
-7.04%-0.76
Diluted earnings per share
37.50%-1.8
89.09%-0.06
62.67%-0.28
23.17%-0.63
-21.05%-0.92
-42.57%-2.88
-139.13%-0.55
-36.36%-0.75
-46.43%-0.82
-7.04%-0.76
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 25.39%40.52M-19.16%24.74M12,265.57%7.54M597.47%3.58M310.40%4.66M-58.64%32.31M-49.03%30.6M-98.86%61K-82.23%513K-88.48%1.14M
Operating revenue 25.39%40.52M-19.16%24.74M12,265.57%7.54M597.47%3.58M310.40%4.66M-58.64%32.31M-49.03%30.6M-98.86%61K-82.23%513K-88.48%1.14M
Cost of revenue
Gross profit
Operating expense -48.44%139.86M-40.34%38.76M-51.18%32.09M-59.90%29.04M-41.33%39.97M9.68%271.23M-22.67%64.97M18.43%65.73M54.14%72.42M12.03%68.13M
Selling and administrative expenses -30.68%49.9M-30.58%11.35M-31.91%12.32M-29.37%12.86M-30.84%13.38M3.35%71.99M13.14%16.35M20.69%18.09M5.84%18.21M-15.95%19.34M
-General and administrative expense -30.68%49.9M-30.58%11.35M-31.91%12.32M-29.37%12.86M-30.84%13.38M3.35%71.99M13.14%16.35M20.69%18.09M5.84%18.21M-15.95%19.34M
Research and development costs -54.85%89.95M-43.63%27.4M-58.49%19.78M-70.15%16.18M-45.49%26.59M12.16%199.25M-30.11%48.61M17.59%47.64M82.04%54.21M29.05%48.79M
Operating profit 58.42%-99.34M59.21%-14.02M62.62%-24.55M64.59%-25.46M47.29%-35.31M-41.22%-238.92M-43.40%-34.36M-30.91%-65.67M-63.07%-71.9M-31.46%-66.99M
Net non-operating interest income expense -84.79%2.14M78.18%2.14M-116.09%-568K-98.44%67K-90.07%500K-19.95%14.06M-76.46%1.2M-31.38%3.53M12.75%4.3M43.49%5.04M
Non-operating interest income -48.87%8.31M-50.58%1.68M-48.13%1.83M-51.43%2.09M-46.06%2.72M-7.48%16.25M-33.54%3.39M-31.38%3.53M12.75%4.3M43.49%5.04M
Non-operating interest expense 181.78%6.17M-121.19%-464K--2.4M--2.02M--2.22M--2.19M--2.19M--0--0--0
Other net income (expense) -413.80%-62.86M6.26M80.00%-1K-2,783,900.00%-27.84M-688,066.67%-41.28M-662.78%-12.24M-5K85.71%-1K100.38%6K
Special income (charges) -396.03%-60.67M151.19%6.26M--0---26.08M---40.85M---12.23M---12.23M--0--0--0
-Less：Restructuring and merger&acquisition 396.03%60.67M-67.21%4.01M--0--24.28M--32.38M--12.23M--12.23M--0--0--0
-Less:Other special charges --------------1.8M--4.75M--------------------
-Write off ----------0--0--3.72M------------------0
Other non- operating income (expenses) -72,866.67%-2.19M---5K80.00%-1K-175,700.00%-1.76M-7,183.33%-425K99.81%-3K-------5K85.71%-1K100.38%6K
Income before tax 32.49%-160.06M87.62%-5.62M59.58%-25.12M21.26%-53.24M-22.82%-76.09M-54.74%-237.09M-140.52%-45.4M-38.03%-62.14M-67.80%-67.61M-26.34%-61.95M
Income tax
Net income 32.49%-160.06M87.62%-5.62M59.58%-25.12M21.26%-53.24M-22.82%-76.09M-54.74%-237.09M-140.52%-45.4M-38.03%-62.14M-67.80%-67.61M-26.34%-61.95M
Net income continuous Operations 32.49%-160.06M87.62%-5.62M59.58%-25.12M21.26%-53.24M-22.82%-76.09M-54.74%-237.09M-140.52%-45.4M-38.03%-62.14M-67.80%-67.61M-26.34%-61.95M
Minority interest income
Net income attributable to the parent company 32.49%-160.06M87.62%-5.62M59.58%-25.12M21.26%-53.24M-22.82%-76.09M-54.74%-237.09M-140.52%-45.4M-38.03%-62.14M-67.80%-67.61M-26.34%-61.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.49%-160.06M87.62%-5.62M59.58%-25.12M21.26%-53.24M-22.82%-76.09M-54.74%-237.09M-140.52%-45.4M-38.03%-62.14M-67.80%-67.61M-26.34%-61.95M
Basic earnings per share 37.50%-1.889.09%-0.0662.67%-0.2823.17%-0.63-21.05%-0.92-42.57%-2.88-139.13%-0.55-36.36%-0.75-46.43%-0.82-7.04%-0.76
Diluted earnings per share 37.50%-1.889.09%-0.0662.67%-0.2823.17%-0.63-21.05%-0.92-42.57%-2.88-139.13%-0.55-36.36%-0.75-46.43%-0.82-7.04%-0.76
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -